StockVS

NASDAQ · Medical Instruments & Supplies · USD

Align Technology, Inc. (ALGN) Stock Analysis

Align Technology, Inc. (ALGN) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

ALGN

$158.64

−$1.22 (−0.76%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ALGN with… →

ALGN Key Statistics

As of Sep 4, 2026
Trading
Open
$157.67
Previous Close
$159.86
Day's Range
155.24–160.50
52-Week Range
122.00–200.44
Volume
990.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.64
Valuation
Market Cap
$11.27B
P/E Ratio
27.59
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.64
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.67
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.72
EPS (ttm)Profit attributable to each share over the last twelve months.
5.75
Financials (FY)
Revenue (FY)
$4.03B+0.90%
Net Income (FY)
$410.35M−2.61%
Profit marginThe share of revenue left as profit after all costs and taxes.
9.99%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
71.04M
1-Year Return
+17.77%
Dividend and dates
Earnings Date
October 28, 2026
Avg Volume
965.10K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ALGN Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+1.59%
2025−25.11%
2024−23.90%
2023+29.92%
2022−67.91%
2021+22.98%
2020+91.51%
2019+33.24%
2018−5.74%
2017+131.13%
2016 (partial year)+4.72%

As of September 4, 2026.

ALGN Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$4.03B$410.35M10.2%
2024$4.00B$421.36M10.5%
2023$3.86B$445.05M11.5%
2022$3.73B$361.57M9.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.03B$2.71B$585.31M$410.35M10.2%
2024$4.00B$2.80B$671.76M$421.36M10.5%
2023$3.86B$2.71B$656.65M$445.05M11.5%
2022$3.73B$2.63B$654.05M$361.57M9.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ALGN Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricALGNMedical Instruments & Supplies medianvs median
P/E27.5935.6123% below
P/S ratio2.723.1714% below
Profit margin9.99%0.85%9.1 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Align Technology, Inc. (ALGN) is capitalised at $11.27B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 20,435 employees.

The most recent close on file for ALGN is $158.64, dated September 4, 2026. That is −$1.22 (−0.76%) against the previous close. The 52-week range on file runs from $122.00 to $200.44. The latest close sits 30.03% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.03B. That is +0.90% against the prior fiscal year, when revenue was $4.00B. The same year closed with net income of $410.35M. That is −2.61% against the prior fiscal year. The reported profit margin is 9.99%. That is 9.1 percentage points above the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are 5.75.

Across the 4 fiscal years on file, revenue moves from $3.73B in 2022 to $4.03B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 27.59 times earnings. That is 22.53% below the Medical Instruments & Supplies median of 35.61. The forward P/E on file is 12.64. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.67. The price-to-sales ratio is 2.72. On price-to-sales that is 14.2% below the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Over the trailing twelve months the price has returned +17.77%. Across 10 years the annualized return works out at +5.18%. Beta against the wider market is reported at 1.64. Annualized volatility over the trailing 10 years is 49.38%.

Growth & Income

The record shows no dividend for ALGN.

Across the complete calendar years on file, 2017 returned +131.13% and 2022 returned −67.91%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the price is +1.59% year to date.

Peer Comparison

Align Technology, Inc. (ALGN) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Align Technology, Inc. ALGN $11.27B 27.6
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Align Technology, Inc. trades at a P/E of 27.6.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Align Technology, Inc.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Visit website →